Evaluation of angiotensin converting enzyme 2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that uses angiotensin converting enzyme 2 (ACE2), a pivotal member of the renin-angiotensin system (RAS), as its cell-entry receptor. Another member of the RAS, angiotensin II (Ang II), is the major biologicall...
Saved in:
Published in | BMC infectious diseases Vol. 24; no. 1 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
BioMed Central Ltd
22.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that uses angiotensin converting enzyme 2 (ACE2), a pivotal member of the renin-angiotensin system (RAS), as its cell-entry receptor. Another member of the RAS, angiotensin II (Ang II), is the major biologically active component in this system. There is growing evidence suggesting that serum miRNAs could serve as prognostic biomarkers for SARS-CoV-2 infection and regulate ACE2 expression. Therefore, the aim of this study is to evaluate the changes in the serum levels of sACE2 and Ang II, as well as the expression level of miR-141-3p and miR-421 in SARS-CoV-2 positive and negative subjects. In the present study, the serum levels of sACE2 and Ang II were measured in 94 SARS-CoV-2 positive patients and 94 SARS-CoV-2 negative subjects with some symptoms similar to those of SARS-CoV-2 positive patients using the ELISA method. In addition, the expression level of miR-141-3p and miR-421 as ACE2 regulators and biomarkers was evaluated using quantitative real-time PCR (qRT-PCR) method. The mean serum sACE2 concentration in the SARS-CoV-2-positive group was 3.268 [+ or -] 0.410 ng/ml, whereas in the SARS-CoV-2 negative group, it was 3.564 [+ or -] 0.437 ng/ml. Additionally, the mean serum Ang II level in the SARS-CoV-2 positive and negative groups were 60.67 [+ or -] 6.192 ng/L and 67.97 [+ or -] 6.837 ng/L, respectively. However, there was no significant difference in the serum levels of sACE2 (P value: 0.516) and Ang II (P value: 0.134) between the SARS-CoV-2 positive and negative groups. Meanwhile, our findings indicated that the expression levels of miR-141-3p and miR-421 in SARS-CoV-2 positive group were significantly lower and higher than SARS-CoV-2 negative group, respectively (P value < 0.001). Taken together, the results of this study showed that the serum levels of sACE2 and Ang II in SARS-CoV-2 positive and negative subjects were not significantly different, but the expression levels of miR-141-3p and miR-421 were altered in SARS-CoV-2 positive patients which need more investigation to be used as biomarkers for COVID-19 diagnosis. |
---|---|
AbstractList | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that uses angiotensin converting enzyme 2 (ACE2), a pivotal member of the renin-angiotensin system (RAS), as its cell-entry receptor. Another member of the RAS, angiotensin II (Ang II), is the major biologically active component in this system. There is growing evidence suggesting that serum miRNAs could serve as prognostic biomarkers for SARS-CoV-2 infection and regulate ACE2 expression. Therefore, the aim of this study is to evaluate the changes in the serum levels of sACE2 and Ang II, as well as the expression level of miR-141-3p and miR-421 in SARS-CoV-2 positive and negative subjects. In the present study, the serum levels of sACE2 and Ang II were measured in 94 SARS-CoV-2 positive patients and 94 SARS-CoV-2 negative subjects with some symptoms similar to those of SARS-CoV-2 positive patients using the ELISA method. In addition, the expression level of miR-141-3p and miR-421 as ACE2 regulators and biomarkers was evaluated using quantitative real-time PCR (qRT-PCR) method. The mean serum sACE2 concentration in the SARS-CoV-2-positive group was 3.268 [+ or -] 0.410 ng/ml, whereas in the SARS-CoV-2 negative group, it was 3.564 [+ or -] 0.437 ng/ml. Additionally, the mean serum Ang II level in the SARS-CoV-2 positive and negative groups were 60.67 [+ or -] 6.192 ng/L and 67.97 [+ or -] 6.837 ng/L, respectively. However, there was no significant difference in the serum levels of sACE2 (P value: 0.516) and Ang II (P value: 0.134) between the SARS-CoV-2 positive and negative groups. Meanwhile, our findings indicated that the expression levels of miR-141-3p and miR-421 in SARS-CoV-2 positive group were significantly lower and higher than SARS-CoV-2 negative group, respectively (P value < 0.001). Taken together, the results of this study showed that the serum levels of sACE2 and Ang II in SARS-CoV-2 positive and negative subjects were not significantly different, but the expression levels of miR-141-3p and miR-421 were altered in SARS-CoV-2 positive patients which need more investigation to be used as biomarkers for COVID-19 diagnosis. |
Audience | Academic |
Author | Rahimi Foroushani, Abbas Shafiei Jandaghi, Nazanin Zahra Yavarian, Jila Mokhtari-Azad, Talat Shayestehpour, Mohammad Sadeghi, Kaveh Mirhendi, Hossein Kakavandi, Ehsan |
Author_xml | – sequence: 1 fullname: Kakavandi, Ehsan – sequence: 2 fullname: Sadeghi, Kaveh – sequence: 3 fullname: Shayestehpour, Mohammad – sequence: 4 fullname: Mirhendi, Hossein – sequence: 5 fullname: Rahimi Foroushani, Abbas – sequence: 6 fullname: Mokhtari-Azad, Talat – sequence: 7 fullname: Shafiei Jandaghi, Nazanin Zahra – sequence: 8 fullname: Yavarian, Jila |
BookMark | eNqFjkFLw0AQRhepYFv9A55y9bA6s5PM7h5LqbZQKFjxGrbJJETqBty0qL_egh568_R9h8fjTdQo9lGUukW4R3T8kNA46zWYXIMnBE0Xaoy5RW2I8tHZv1KTlN4A0Drjx0ovjmF_CEPXx6xvshDbrh8kpi5mVR-P8jF0sc0kfn-9S2au1WUT9klu_naqto-Ll_lSrzdPq_lsrVt2rAsmroumCvWuDp4YaobcGXRAnHvy7BpXFGCZxCBwxRaoksIjS1OZHU3V3a-1DXspu3gKGeRzaMMhpXK1fS5n1uOpHz3_w25ez9kfInlUkg |
ContentType | Journal Article |
Copyright | COPYRIGHT 2024 BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2024 BioMed Central Ltd. |
DBID | IOV ISR |
DOI | 10.1186/s12879-024-09310-3 |
DatabaseName | Gale In Context: Opposing Viewpoints Science in Context |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2334 |
ExternalDocumentID | A791178196 |
GeographicLocations | Iran |
GeographicLocations_xml | – name: Iran |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB |
ID | FETCH-LOGICAL-g686-5636d5fcadbda9360d6048218036493968f8550763e2106c6703ce5916efc2b3 |
IEDL.DBID | M48 |
ISSN | 1471-2334 |
IngestDate | Fri Jun 27 05:43:18 EDT 2025 Fri Jun 27 06:12:44 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-g686-5636d5fcadbda9360d6048218036493968f8550763e2106c6703ce5916efc2b3 |
ParticipantIDs | gale_incontextgauss_ISR_A791178196 gale_incontextgauss_IOV_A791178196 |
PublicationCentury | 2000 |
PublicationDate | 20240422 |
PublicationDateYYYYMMDD | 2024-04-22 |
PublicationDate_xml | – month: 04 year: 2024 text: 20240422 day: 22 |
PublicationDecade | 2020 |
PublicationTitle | BMC infectious diseases |
PublicationYear | 2024 |
Publisher | BioMed Central Ltd |
Publisher_xml | – name: BioMed Central Ltd |
SSID | ssj0017829 |
Score | 2.389362 |
Snippet | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that uses angiotensin converting enzyme 2 (ACE2), a pivotal member of... |
SourceID | gale |
SourceType | Aggregation Database |
SubjectTerms | Analysis Angiotensin converting enzyme Biological markers MicroRNA |
Title | Evaluation of angiotensin converting enzyme 2 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwEA9zgvgifuLnKOJrdG3aS_MgMmVjClPYnAxfRtMmRdAM1w2cf72X2OkeJvhSQgkHyXH3y4_7IuSM-0IjO45pmumEIt8QVCJM4AqxJRAhKGWLkzv30O6Hd4NoUCHzcUflBRZLqZ2dJ9Ufv55_vM-u0OAvncHHcFGgj-WCItpQ5OfWr6yQVUQmbicadMLfqAKioXDVRtynAWPhvIhmqYzSRy-gTWuTbJTPRK_xrdctUlFmm6x1ykD4DqHNny7d3kh7iclfRi4X3Xguj9z2Bsg9ZT5nb8oLdkmv1Xy8adNy8gHNIQYaAYMs0mmSySwRDOoZoKEhGNugoWACYu36kAFTyNggBTRbW07lg9JpINkeqZqRUfvEQylRHf_EXCnUg5YCLTiLIuknXMuQH5BTe8ih7QRhbKpJnkyLYnj78DRscPSDHB8M8NemXndh0-F_JB2R9cBdcUiD4JhUJ-OpOkFQn8iaI8M1py_8dq-fvwBhTpxq |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+angiotensin+converting+enzyme+2&rft.jtitle=BMC+infectious+diseases&rft.au=Kakavandi%2C+Ehsan&rft.au=Sadeghi%2C+Kaveh&rft.au=Shayestehpour%2C+Mohammad&rft.au=Mirhendi%2C+Hossein&rft.date=2024-04-22&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2334&rft.eissn=1471-2334&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs12879-024-09310-3&rft.externalDBID=IOV&rft.externalDocID=A791178196 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |